endo150Endo Tools Therapeutics (ETT) develops incisionless medical devices to treat morbid obesity, digestive tract tumors and type 2 diabetes. Endomina platform, currently under clinical trial, allows full-thickness tissue apposition in the stomach. It will come to market this year.

ETT is a spin-off from the Brussels University ULB.

<back to exhibitors